FDA cites Chinese firm's manufacturing processes for heparin (Park Hills Daily Journal)
WASHINGTON (AP) China and the United States traded charges Monday about whether a contaminant in the blood thinner heparin caused severe allergic reactions linked to as many as 81 deaths.

Progenics and Wyeth Announce FDA Has Approved RELISTOR (Centre Daily Times)
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that the U.S. Food and Drug Administration (FDA) has approved RELISTOR(TM) (methylnaltrexone bromide) subcutaneous injection for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to laxative ...